============================================================================= Run Date: MAR 24, 2014 Designation: GMRA*4*47 Package : GMRA - ADVERSE REACTION TRACKING Priority: Mandatory Version : 4 SEQ #43 Status: Released Compliance Date: JUL 31, 2014 ============================================================================= Associated patches: (v)GMRA*4*45 <<= must be installed BEFORE `GMRA*4*47' (v)OR*3*345 <<= must be installed BEFORE `GMRA*4*47' Subject: MOCHA 2.0 FOLLOW-UP Category: - Routine Description: ============ This patch is part of a group of host file patches that make up the new Medication Order Check Healthcare Application v2.0 (MOCHA). These patches contain software that supports MOCHA v2.0 functionality. The host files were created to simplify installation at Veterans Health Administration (VHA) facilities. Patch Information: ------------------ The following patches will be distributed in a phased release and sites will be given access to them during their scheduled phase of implementation: 1. PSS_1_160.KID 2. PSS_1_173.KID 3. MOCHA_2_0.KID contains: PSO*7*372, PSJ*5*252, and OR*3*345 4. MOCHA_2_0_FOLLOW_UP_COMBINED_BUILD.KID contains: PSO*7*416, PSJ*5*257, GMRA*4*47, and OR*3*311. 5. OR_3_381.KID 6. MOCHA_2_0_FAST_TRACK_BUILDS.KID contains: PSO*7*431, PSJ*5*299 **NOTE** PSS_1_160 and PSS_1_173 include the components necessary for the interface that will be used in MOCHA v2.0. The MOCHA 2.0 and MOCHA 2.0 FOLLOW UP COMBINED BUILD include the modifications to implement Max Single Dose Order checks for the Order Entry Results Reporting (OERR), Inpatient Medications and Outpatient Pharmacy applications. These patches will add a maximum single dose order check to the current VistA medication order checking system that uses the First DataBank (FDB) business logic and database. In this initial phase of dosing functionality, the Maximum Single Dose information will be displayed to the user. The following scenarios describe the types of messaging added: 1. If the dosage entered passes the dosing checks, no message will be displayed. 2. If the dosage entered is too high, the Single Dose warning message will be displayed. 3. If the dose checks were not able to be performed, a generic message will be displayed notifying the user that a manual check needs to be completed to verify appropriate dosing. This is a companion patch to the Order Entry/Results Reporting (OE/RR) version 3.0 software patch number 345 (OR*3*345). Patch OR*3*345 makes a change to the EN^ORKCHK application programming interface (API) that the Adverse Reaction Tracking (GMRA) software package uses under integration agreement number 4135. This patch enables the GMRA package to use the updated API. Patch Components ================ Files & Fields Associated: File Name (Number) Field Name (Number) New/Modified/Deleted ------------------ ------------------- -------------------- N/A Forms Associated: Form Name File # New/Modified/Deleted --------- ------ -------------------- N/A Mail Groups Associated: Mail Group Name New/Modified/Deleted --------------- -------------------- N/A Options Associated: Option Name Type New/Modified/Deleted ----------- ---- -------------------- GMRA FREE TEXT UTILITY Run Routine Modified Protocols Associated: Protocol Name New/Modified/Deleted ------------- -------------------- N/A Security Keys Associated: Security Key Name ----------------- N/A Templates Associated: Template Name Type File Name (Number) New/Modified/Deleted ------------- ---- ------------------ -------------------- N/A Additional Information: New Service Requests (NSRs) ---------------------------- N/A Patient Safety Issues (PSIs) ----------------------------- N/A Remedy Ticket(s) & Overview --------------------------- 1. 778406 Adverse Reaction Tracking - Cleanup: Problem: ------- When executing the Allergy clean up utility [GMRA FREE TEXT UTILITY] option with patch OR*3*345 installed, the following error is generated: PHARM+5^ORKCHK5 *ORDODSG This error is generated when the GMRA package uses OE/RR's order checking system to determine if any current orders could result in an adverse reaction based on the updated allergy data. Resolution: ---------- This patch updates all calls to EN^ORKCHK within the GMRA package. Test Sites: ---------- Charleston Tuscaloosa Kansas Boise Palo Alto Northern California - Martinez Patch Installation: Installation Instructions ------------------------- The following patches will be distributed in a phased release and sites will be given access to the host files during their scheduled phase of implementation: 1. PSS_1_160.KID 2. PSS_1_173.KID 3. MOCHA_2_0.KID contains: PSO*7*372, PSJ*5*252, and OR*3*345 4. MOCHA_2_0_FOLLOW_UP_COMBINED_BUILD.KID contains: PSO*7*416, PSJ*5*257, GMRA*4*47, and OR*3*311. 5. OR_3_381.KID - HOST file with patch name OR*3*381. 6. MOCHA_2_0_FAST_TRACK_BUILDS.KID contains: PSJ*5*299, PSO*7*431 To find out your wave deployment status, please see: http://vaww.oed.portal.domain.ext/projects/pre/PRE_M2_Deploy_Trng/PRE_VA_User_ M2_Deploy_Trng/SitePages/Home.aspx Refer to the MOCHA v2.0 Installation Guide PSS_1_P160_MOCHA_CB_IG.doc. Routine Information: ==================== The second line of each of these routines now looks like: ;;4.0;Adverse Reaction Tracking;**[Patch List]**;Mar 29, 1996;Build 3 The checksums below are new checksums, and can be checked with CHECK1^XTSUMBLD. Routine Name: GMRAFX3 Before: B69479598 After: B70101558 **17,19,23,20,45,47** Routine Name: GMRAUTL2 Before: B88611028 After: B90558602 **23,36,41,45,47** Routine list of preceding patches: 45 ============================================================================= User Information: Entered By : Date Entered : NOV 19, 2012 Completed By: Date Completed: MAR 24, 2014 Released By : Date Released : MAR 24, 2014 ============================================================================= Packman Mail Message: ===================== No routines included